cromolyn sodium has been researched along with Breast Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| El-Maraghy, SA; Motawi, TK; Nady, OM; Sabry, D; Senousy, MA | 1 |
| Corwin, MA; Samoszuk, M | 1 |
| Rodenhuis, S; ten Bokkel Huinink, WW; Westermann, AM | 1 |
3 other study(ies) available for cromolyn sodium and Breast Neoplasms
| Article | Year |
|---|---|
Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice.
Topics: Animals; Ascites; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Chitosan; Cromolyn Sodium; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genes, p16; Heterografts; Humans; Mice; Nanoparticles; RNA, Neoplasm | 2022 |
Mast cell inhibitor cromolyn increases blood clotting and hypoxia in murine breast cancer.
Topics: Adenocarcinoma; Animals; Anti-Asthmatic Agents; Blood Coagulation; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Case-Control Studies; Cell Hypoxia; Cromolyn Sodium; Female; Humans; Mammary Neoplasms, Experimental; Mast Cells; Mice; Mice, Inbred BALB C; Neoplasm Staging; Serine Endopeptidases; Thrombosis; Tryptases | 2003 |
Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions.
Topics: Administration, Oral; Anti-Asthmatic Agents; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cromolyn Sodium; Docetaxel; Drug Hypersensitivity; Female; Humans; Middle Aged; Paclitaxel; Taxoids | 1996 |